Remove Diabetes Remove Family Practice Remove Information Remove Medical
article thumbnail

ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes

Physician's Weekly

from the Velocity Clinical Research Center at Medical City Dallas, and colleagues conducted a phase 3 trial involving participants with type 2 diabetes treated only with diet and exercise, an HbA1c level of ≥7.0 Abstract/Full Text (subscription or payment may be required) More Information Copyright © 2025 HealthDay.

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

The combination pill is the first and only FDA-approved triple combination medication for use as an initial therapy in patients who will likely need multiple drugs to achieve their ideal blood pressure numbers. More Information Copyright © 2025 HealthDay. ” The approval of Widaplik was granted to George Medicines.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Insurers Promise to Speed Up Delays in Health Care Approvals

Physician's Weekly

It’s “going to streamline it in some incremental ways only,” Dr. Adam Gaffney , a critical care doctor and assistant professor at Harvard Medical School, told NBC News. Medical professionals will be required to review all denials (though insurers say they already do this). But experts say the changes may not go far enough.

article thumbnail

What We Now Know About COVID Prevention and Treatment: A Podcast with Monica Gandhi

GeriPal

But we have very little information, almost no information. And to be very fair, there was a study in 2013 in family practice, this would be important, I think for those who treat older patients. And so there are other new treatments that I hope also will inform RSV and other RNA viruses. Eric: Yeah.